Daniel Levitt

Overview

Daniel Levitt received an average of $2M in total compensation, including $558K in salary, at CytRx from 2013 to 2015.

Source: SEC filing on May 20, 2016.

Related executives

We found six more executives who work or worked at CytRx.

Stephen Snowdy

CytRx

Chief Executive Officer

John Caloz

CytRx

Chief Financial Officer

Steven Kriegsman

CytRx

Chief Executive Officer

Felix Kratz

CytRx

Vice President – Drug Development

Benjamin Levin

CytRx

General Counsel

Scott Wieland

CytRx

Senior Vice President – Drug Development

You may also like